These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36965889)

  • 41. [A prospective cohort study on the impact of placement timing of LNG-IUS for adenomyosis].
    Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Liu ZZ; You SS; Chang XY; Lang YH
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2415-20. PubMed ID: 27545034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF; Singh K
    Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness.
    Sun F; Zhang Y; You M; Yang Y; Yu Y; Xu H
    J Obstet Gynaecol Res; 2021 Feb; 47(2):613-620. PubMed ID: 33174318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
    Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review.
    Rathinam KK; Abraham JJ; S HP; S A S; Sen M; George M; A P
    Eur J Clin Pharmacol; 2022 Apr; 78(4):531-545. PubMed ID: 35037089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study.
    Kim MK; Chon SJ; Lee JH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
    Reprod Sci; 2018 Jan; 25(1):39-43. PubMed ID: 28683602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of levonorgestrel-releasing intrauterine system on lymphangiogenesis of adenomyosis.
    Cho S; Choi YS; Yun BH; Chon SJ; Jung YS; Kim H; Park JH; Seo SK; Kim SH; Lee BS
    Am J Clin Pathol; 2015 Mar; 143(3):352-61. PubMed ID: 25696793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes of menstruation patterns and adverse effects during the treatment of LNG-IUS for symptomatic adenomyosis].
    Li L; Leng JH; Zhang JJ; Jia SZ; Li XY; Shi JH; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):657-662. PubMed ID: 27671045
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding.
    Yang H; Wang S; Fu X; Lan R; Gong H
    J Obstet Gynaecol Res; 2022 Jan; 48(1):161-168. PubMed ID: 34672405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
    Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials.
    Wang J; Deng K; Li L; Dai Y; Sun X
    Front Glob Womens Health; 2022; 3():1013921. PubMed ID: 36405811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
    Varma R; Sinha D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):9-28. PubMed ID: 16325993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
    Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
    Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
    Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
    BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.
    Liang Z; Yin M; Ma M; Wang Y; Kuang Y
    Reprod Biomed Online; 2019 Jul; 39(1):111-118. PubMed ID: 31109894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.